Ted Jenkins | Vice President, Investor Relations and Strategic Finance |
Sath Shukla | Chief Executive Officer |
Kamal Hamed | Chief Medical Officer |
Steve Dipalma | Interim Chief Financial Officer and Treasurer |
Louise Chen | Cantor |
Boobalan Pachaiyappan | H.C. Wainwright |
Ritu Baral | Cowen |
Good afternoon and welcome to the Spero Therapeutics Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded and a replay will be available.
You can find information on the replay and further information related to today’s announcements on the Spero Therapeutics website at www.sperotherapeutics.com. At this time, I would like to turn the call over to Ted Jenkins, Vice President, Investor Relations and Strategic Finance at Spero Therapeutics. Mr.